'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery

被引:30
作者
Wang, Li
Sun, Yan
Dul, Feifei
Niu, Wei
Lu, Tong
Kan, Jingmin
Xu, Fang
Yuan, Kaihong
Qin, Tao
Liu, Changxiao
Li, Chuan
机构
[1] Chinese Acad Sci, SIBS, Shanghai Inst Mat Med, Shanghai Ctr DMPK Res,Grad Sch, Shanghai 201203, Peoples R China
[2] Jiangsu Hengrui Med Co Ltd, Jiansu 222002, Peoples R China
[3] Tianjin Inst Pharmaceut Res, Tianjin State Key Lab Pharmacodynam & Pharmacokin, Tianjin 300193, Peoples R China
关键词
D O I
10.1002/rcm.3129
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The development of rapid and sensitive bioanalytical methods in a short time frame with acceptable levels of precision and accuracy is imperative for successful drug discovery. We previously reported that the use of a mobile phase containing an extremely low concentration of ammonium formate or formic acid increased analyte electrospray ionization (ESI) response and controlled against matrix effects. We designated these favorable effects 'LC-electrolyte effects'. In order to support rapid pharmacokinetic (PK) studies for drug discovery, we applied LC-electrolyte effects to the development of generic procedures that can be used to quickly generate reliable PK data for compound candidates. We herein demonstrate our approach using four model tested compounds (Compd-A, -B, -C, and -D). The analytical methods involve generic protein precipitation for sample clean-up, followed by application of fast liquid chromatographic (LC) gradients and the subsequent use of electrospray ionization tandem mass spectrometry (ESI-MS/MS) for individual measurement of the tested compounds in 20-mu L plasma samples. Good linearity over the concentration range of 1.6 or 8-25000 ng/mL (r(2) > 0.99), precision (RSD, 0.45-13.1%), and accuracy (91-112%) were achieved through the use of a low dose of formic acid (0.4 mM or 0.015%.) in the methanol/water-based LC mobile phase. The analytical method was quite sensitive, providing a lower limit of quantification of 1.6 pg on-column except for Compd-C (8 pg), and showed negligible ion suppression caused by matrix components. Finally, the assay suitability was demonstrated in simulated discovery PK studies of the tested compounds with i.v./p.o. dosing of rats. This new assay approach has been adopted with good results in our laboratory for many recent discovery PK studies. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:2573 / 2584
页数:12
相关论文
共 30 条
[1]   High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism [J].
Ansede, JH ;
Thakker, DR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (02) :239-255
[2]   Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput [J].
Berman, J ;
Halm, K ;
Adkison, K ;
Shaffer, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :827-829
[3]   Rapid assessment of drug metabolism in the drug discovery process [J].
Bertrand, M ;
Jackson, P ;
Walther, B .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S61-S72
[4]  
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO
[5]  
2-0
[6]   Effect of liquid chromatography separation of complex matrices on liquid chromatography-tandem mass spectrometry signal suppression [J].
Choi, BK ;
Hercules, DM ;
Gusev, AI .
JOURNAL OF CHROMATOGRAPHY A, 2001, 907 (1-2) :337-342
[7]   Novel in vivo procedure for rapid pharmacokinetic screening of discovery compounds in rats [J].
Cox, KA ;
Dunn-Meynell, K ;
Korfmacher, WA ;
Broske, L ;
Nomeir, AA ;
Lin, CC ;
Cayen, MN ;
Barr, WH .
DRUG DISCOVERY TODAY, 1999, 4 (05) :232-237
[8]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[9]   ADME/PK as part of a rational approach to drug discovery [J].
Eddershaw, PJ ;
Beresford, AP ;
Bayliss, MK .
DRUG DISCOVERY TODAY, 2000, 5 (09) :409-414
[10]  
Jemal M, 1998, RAPID COMMUN MASS SP, V12, P429, DOI 10.1002/(SICI)1097-0231(19980430)12:8<429::AID-RCM179>3.0.CO